Mobile handheld ultrasound with VScan Air for the diagnosis of deep vein thrombosis

Ulrich Kaiser(University of Applied Sciences Landshut), Ernst-Michael Jung(University Hospital Regensburg), Barbara Greiner(University Hospital Regensburg), Christian Stroszczynski(University Hospital Carl Gustav Carus), Wolfgang Herr(University Hospital Regensburg)

Clinical Hemorheology and Microcirculation

October 21, 2022

10.3233/ch-221598

Cited by 13

Related Papers

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

|The Lancet|2013|1.5k

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

|The Lancet Oncology|2009|960

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial

|The Lancet Oncology|2015|402

Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy

|Cell Reports|2019|297

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)

|Annals of Oncology|2006|280